Skip to main content
Fig. 4 | BMC Urology

Fig. 4

From: Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma

Fig. 4

Prognosis capability of the model in the three patient sets. (A-C)Risk score distribution, survival status and heatmap for BLCA patients in high-risk and low-risk groups in the entire cohort. (D-F Risk score distribution, survival status and heatmap for BLCA patients in high-risk and low-risk groups in the test cohort. (G-I Risk score distribution, survival status and heatmap for BLCA patients in high-risk and low-risk groups in the train cohort.(J-K) Stage I-II and Stage III-IV survival analysis in the high- and low-risk groups. (L) Kaplan–Meier curves of progression-free survival. (M-O) Kaplan–Meier curves for overall survival analysis in the entire, test and train cohort. BLCA, bladder urothelial carcinoma

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us